SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Starfighters Space Inc

Starfighters Space Inc. (FJET) is experiencing explosive upward momentum following its recent IPO, driven by intense community enthusiasm for the space sector. Traders are actively discussing its significant gains, anticipating further parabolic moves and potential short squeezes, though some express caution regarding its early-stage fundamentals.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid analyst upgrades, including a $45 price target from Jefferies, and anticipation for its CES 2026 showcase of commercial quantum computing applications. The community is sharply divided, with bulls highlighting its "quantum supremacy in optimization" and potential as an AI enabler, while bears decry it as a "manipulated pump" detached from fundamental value. This intense debate around its role in the emerging quantum sector is driving significant conversation.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending due to intense anticipation surrounding its imminent FDA decision on Narsoplimab for TA-TMA, with many in the community expecting approval by late December. The recent closing of a significant licensing deal with Novo Nordisk has further bolstered financial stability and fueled investor confidence. This combination of a potentially transformative regulatory event, coupled with substantial short interest, has ignited discussions of a major price movement, though some anticipate continued market manipulation ahead of the binary outcome.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is experiencing a surge in conversation following promising drill results from its exploration program, which reported exceptionally high silver grades in the Vortex zone. This news, combined with significant buying activity from a key institutional investor and a generally bullish outlook for precious metals, is fueling widespread community interest. A notable talking point among investors is the recent decision by a former major holder to divest most of its stake in the company, coinciding with its current upward price momentum.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending due to intense community debate centered on alleged market manipulation, with several major brokers reportedly restricting share purchases. This perceived obstruction, coupled with an unfulfilled share buyback program, is fueling deep investor frustration despite recent significant contract announcements and analyst upgrades highlighting its potential in the AI data center sector. While many bulls see explosive short-squeeze potential from the low float and strong fundamentals, others are losing patience, questioning management's actions and the true impact of its multi-billion pipeline.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as excitement builds around its impending merger with Infleqtion, a quantum technology leader. Recent positive analyst coverage, new government contracts, and strategic partnerships, including with NVIDIA, highlight Infleqtion's advanced quantum sensing capabilities and significant revenue pipeline. The community anticipates that the upcoming merger and ticker change to Infleqtion will unlock broader institutional investment and re-rate the stock closer to its quantum peers.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending amid reports of a potential $10 billion investment in OpenAI, which includes OpenAI utilizing Amazon's Trainium AI chips. This development is driving community discussion, with investors, despite past frustrations over stagnant performance, anticipating it could be a significant catalyst to solidify Amazon's AI infrastructure leadership and potentially spark a long-awaited breakout.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its proposed all-stock merger with fusion energy company TAE Technologies, which initially spurred significant upside volatility. The community remains sharply divided, with bulls anticipating a substantial short squeeze and long-term potential from innovative energy and recent Bitcoin investments, while bears widely dismiss it as a "pump and dump" driven by questionable fundamentals and political discourse. Currently, market participants are debating whether the stock will consolidate for another rally or face further declines, as sentiment remains highly polarized.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is highly volatile amid contrasting analyst ratings and intense community debate over its role in the booming AI data center and optical networking sector. Bulls point to growing demand for 800G/1.6T transceivers from hyperscalers like Amazon and Oracle, along with manufacturing expansion, driving expectations for a 'super cycle' repeat. Conversely, recent downgrades and past execution concerns are fueling skepticism, causing sharp price swings as investors weigh future profitability against perceived risks.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Tempe, AZ.

First Solar Inc

First Solar is trending as Alphabet's acquisition of Intersect Power, a significant customer of its photovoltaic modules, directly links FSLR to the escalating energy demands of AI-driven data centers. The community is actively discussing First Solar's strong position with a vertically integrated U.S. supply chain, touting its potential for government contracts and to meet the surging energy needs for AI infrastructure. Many believe FSLR is well-positioned for continued growth, with analysts raising price targets and speculation focusing on its trajectory to new highs as solar demand for AI infrastructure accelerates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Hepion Pharmaceuticals Inc. drew heightened attention from retail traders on Monday after the company disclosed that the Nasdaq Hearings Panel had ordered its delisting, citing violations of continued listing requirements.&nbsp;Trading in the company's common stock is set to be suspended at the open on Tuesday, with shares expected to move to the OTC Markets under the same ticker, HEPA.Hepion Pharmaceuticals shares closed down 18.8% at $0.32 on Monday, sliding 45% to $0.17 in after-hours trading.Retail sentiment on Stocktwits turned 'bullish' on Monday amid a 5,100% surge in 24-hour message volume.One user highlighted optimism around Hepion's core asset, Rencofilstat, describing it as a potentially "revolutionary" drug class.&nbsp;Rencofilstat is a cyclophilin inhibitor aimed at treating chronic liver diseases like NASH and hepatocellular carcinoma (HCC).The user suggested that although trial results may not be released soon, the drug could eventually displace existing therapies once they have been fully monetized.&nbsp;They added that the move to OTC "could get interesting."<stembedurl>https://stocktwits.com/BADBOYROY/message/614371348</stembedurl>Another user hoped the stock would be tradable on Robinhood after moving to the OTC market, suggesting the transition could trigger a strong upward move.<stembedurl>https://stocktwits.com/stock_trafficking/message/614386549</stembedurl>The delisting followed Nasdaq's determination that Hepion had failed to maintain the minimum bid price of $1.00 and was in breach of Rule 5101, which allows delisting of companies identified as public shells.Hepion recently entered a license agreement with New Day Diagnostics LLC to distribute tests for celiac disease, respiratory multiplex (COVID-19, Influenza A/B, RSV), H. pylori, and hepatocellular carcinoma (HCC).&nbsp;These tests carry CE marks, making them eligible for sale in Europe.The company had previously paused and then wound down its ASCEND-NASH Phase 2b trial for Rencofilstat, after enrolling 151 patients out of a planned 336.&nbsp;Approximately 80 patients completed a full year of treatment.The stock has declined 98.7% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic picture shows a hand holidng a capsule on 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Hepion Pharma Stock Draws Bullish Retail Bets Despite Nasdaq Delisting Notice: 'Could Get Interesting'

Despite a sharp decline in stock price, retail traders are optimistic about the company's potential, citing its core asset Rencofilstat and speculating on a rebound following the OTC transition.

Equity

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.

Current Price	$0.065
Prev Close	$0.069
Open	$0.069
Dividend Yield	0.00%
50-Day Moving Average	$0.0717
Beta	1.14
Avg. Volume	24,026.00
PE Ratio	-0.01

52-Week High	$36.73
52-Week Low	$0.033
Market Capitalization	$801,802.00
EPS (Annual)	-$107.35
Price to Book	0.49
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

HEPA
Hepion Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest HEPA News

HEPAHepion Pharmaceuticals Inc